INDIVIOR PLC/S (OTCMKTS:INVVY) will be issuing its quarterly earnings data before the market opens on Thursday, February 14th.
INVVY stock opened at $6.88 on Tuesday. The firm has a market cap of $950.43 million, a PE ratio of 3.82 and a beta of 0.34. INDIVIOR PLC/S has a fifty-two week low of $4.73 and a fifty-two week high of $33.83.
INVVY has been the subject of several research reports. Zacks Investment Research downgraded INDIVIOR PLC/S from a “hold” rating to a “sell” rating in a research note on Wednesday, November 28th. ValuEngine downgraded INDIVIOR PLC/S from a “sell” rating to a “strong sell” rating in a research note on Wednesday, November 21st. Finally, Jefferies Financial Group downgraded INDIVIOR PLC/S from a “buy” rating to a “hold” rating in a research note on Wednesday, November 21st.
ILLEGAL ACTIVITY NOTICE: “INDIVIOR PLC/S (INVVY) to Release Quarterly Earnings on Thursday” was first published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2019/02/12/indivior-plc-s-invvy-to-release-quarterly-earnings-on-thursday.html.
About INDIVIOR PLC/S
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, overdose rescue, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex.
Read More: What is a blue-chip stock?
Receive News & Ratings for INDIVIOR PLC/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INDIVIOR PLC/S and related companies with MarketBeat.com's FREE daily email newsletter.